Collagen Solutions PLC Director/PDMR Shareholding (0283M)
25 July 2017 - 8:36PM
UK Regulatory
TIDMCOS
RNS Number : 0283M
Collagen Solutions PLC
25 July 2017
This announcement contains inside information
Collagen Solutions Plc
(the "Company")
Director/PDMR Dealing
Collagen Solutions plc (AIM: COS), the developer and
manufacturer of medical grade collagen components for use in
regenerative medicine, medical devices and in-vitro diagnostics,
announces that it was notified today that David Evans, Chairman of
the Company, has purchased 900,000 ordinary shares in the Company
("Ordinary Shares") at 5.1 pence per Ordinary Share.
Following the transaction, David Evans' total beneficial holding
in the Company has increased to 39,394,554 Ordinary Shares
representing 12.15 per cent. of the issued ordinary share capital
of the Company.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------
a) Name David Evans
--- ------------------------- -------------------------------
2 Reason for the notification
--- ----------------------------------------------------------
a) Position/status Chairman
--- ------------------------- -------------------------------
b) Initial notification Initial
/Amendment
--- ------------------------- -------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------
a) Name Collagen Solutions plc
--- ------------------------- -------------------------------
b) LEI N/A
--- ------------------------- -------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------
a) Description of Ordinary shares of 1p each
the financial
instrument, type
of instrument ISIN: GB00B94T6Y14
Identification
code
--- ------------------------- -------------------------------
b) Nature of the Purchase of shares
transaction
--- ------------------------- -------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------------- ----------
5.1p per share 900,000
---------------- ----------
--- ------------------------- -------------------------------
d) Aggregated information
- Aggregated volume N/A - single transaction
- Price
--- ------------------------- -------------------------------
e) Date of the transaction 25 July 2017
--- ------------------------- -------------------------------
f) Place of the transaction London Stock Exchange
--- ------------------------- -------------------------------
About Collagen Solutions:
Collagen Solutions Plc is a global supplier, developer, and
manufacturer of medical grade collagen, tissues, and related
medical devices and components for use in regenerative medicine,
medical devices and in-vitro diagnostics and research. The Company
is also expanding its range of biomaterials-based finished medical
devices based on its internal and acquired intellectual property
for commercialisation with partners via licensing and distribution
arrangements, including ChondroMimetic, an osteochondral scaffold
for repairing cartilage defects in the knee. The Company's products
are used in a wide variety of applications including orthopaedics,
cardiovascular, dental, plastic surgery, wound healing, neurology
and urology.
For additional information on Collagen Solutions, please visit:
www.collagensolutions.com
Enquiries:
Collagen Solutions Plc Contact via Walbrook
Jamal Rushdy, Chief Executive
Officer
Gill Black, Chief Financial
Officer
Cenkos Securities plc (Nominated Tel: 0207 397 8900
Adviser and Broker)
Stephen Keys
Steve Cox
Callum Davidson
Walbrook PR Tel: 020 7933 8780 or collagen@walbrookpr.com
Mike Wort Mob: 07900 608 002
Anna Dunphy Mob: 07876 741 001
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHOKPDNKBKDQOB
(END) Dow Jones Newswires
July 25, 2017 06:36 ET (10:36 GMT)
Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2024 to May 2024
Collagen Solutions (LSE:COS)
Historical Stock Chart
From May 2023 to May 2024